Filing Details
- Accession Number:
- 0001225208-23-002378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-21 16:19:32
- Reporting Period:
- 2023-02-16
- Accepted Time:
- 2023-02-21 16:19:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566094 | B. Jeffrey Mirviss | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp&Pres, Periph Intervent | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-16 | 2,970 | $0.00 | 92,858 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-16 | 909 | $46.48 | 91,949 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-16 | 1,409 | $46.79 | 90,540 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-17 | 3,333 | $0.00 | 93,873 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-17 | 1,020 | $46.54 | 92,853 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-17 | 2,061 | $46.35 | 90,792 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-18 | 2,817 | $0.00 | 93,609 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-18 | 1,002 | $46.54 | 92,607 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-02-16 | 2,970 | $0.00 | 2,970 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2023-02-17 | 3,333 | $0.00 | 3,333 | $0.00 |
| Common Stock | Deferred Stock Units | Disposition | 2023-02-18 | 2,817 | $0.00 | 2,817 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,910 | 2026-02-16 | No | 4 | M | Direct | |
| 6,667 | 2025-02-17 | No | 4 | M | Direct | |
| 2,817 | 2024-02-18 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
Billionaire Hedge Funds
